About Us

Our team

Consisting of AI researchers, physician scientists, oncologists, pharmacologist, and molecular biologists, our combined expertises afford us unique perspectives addressing unmet needs of precision oncology.

Xinghua Lu, MD, PhD

Interim Chief Executive Officer

Chief Scientific Officer


Dr. Xinghua Lu received his medical degree from the Shandong Medical University and practiced as an internal medicine physician for 10 years. He received his PhD in pharmacology from the University of Connecticut. After further receiving a postdoctoral training in Biomedical Informatics from the University of Pittsburgh, he has been carrying out research in AI and medicine for 20 years.

Min Sun, MD, PhD

Chief Medical Officer


Dr. Min Sun graduated from Peking University School of Medicine in Beijing, China. He received his PhD from Department of Pathology at Case Western Reserve University in Cleveland, Ohio. He completed his internal medicine training and Hem/Onc fellowship at University of Pittsburgh School of Medicine. Dr. Sun has been a medical oncologist at UPMC Hillman Cancer Center since 2005. His research focuses on genomics, proteomics, radiomics, and artificial intelligence in oncology.

Michael Paletta, MS

Chief Marketing Officer


Mr. Paletta received his Master's degree in Psychopharmacology from Yale University. He has worked in the field of precision oncology for more than 20 years, recently as a marketing director at AstraZeneca and prior at Genomic Health (a subsidiary of the Exact Sciences). He has successfully marketed several influential precision oncology products, including Oncotype Dx by the Genomic Health.